Compare Campbell Soup Co. (CPB) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Campbell Soup Co. vs Cassava Sciences Inc — how do they compare? Campbell Soup Co. trades at $22.79 (market cap $6.78B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Campbell Soup Co. is far larger — about 142× Cassava Sciences Inc's market cap, and Campbell Soup Co. pays a 6.87% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| CPB | FLNA | |
|---|---|---|
Market Cap | $6.78B | $47.75M |
Sector | Consumer Staples | Health |
52-Week High | $34.03 | $4.64 |
52-Week Low | $20.00 | $0.87 |
Enterprise Value | $13.38B | -$34.93M |
Dividend Yield | 6.87% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Campbell Soup Co.
With a history that dates back around 150 years, Campbell Soup is now a leading manufacturer and marketer of branded convenience food products, most notably soup. The firm's product assortment includes well-known brands like Campbell's, Pace, Prego, Swanson, V8, and Pepperidge Farm. Following the sale of its international snacking operations, which wrapped in calendar 2019, the firm derives nearly all of its sales from its home turf. Campbell has made a handful of acquisitions to reshape its product mix the past few years, including the tie-up with Snyder's-Lance (completed in March 2018), which enhances its exposure to the faster-growing on-trend snack food aisle, complementing its Pepperidge Farm lineup.
Read more on CPB →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
